Official company update
N-iX and COGNANO partner to scale AI and data infrastructure for antibody drug discovery
ApplyDjinn context
What else is visible for N-iX?
These are observations in our catalog around the company, not claims made by the article. A publication does not establish why hiring, search interest, or share prices moved.
Current roles
99
30-day current-market scope
Company stories · 30d
2
2 official · 0 independent
Attention records · 7d
0
0 Google · 0 Polymarket
Coverage mix
Attention sources
No matching record in this window.
Open roles
99
Technical roles
83 of 99
Observed hiring change
+2 roles
Hiring and market history
Daily vacancy snapshots show this company’s observed hiring; no standalone public ticker is assigned.
Vacancy history
Current role mix
83 technical · 16 other
84% of currently observed roles are technical.
Vacancy history uses saved daily snapshots through 2026-10-11. News counts are dated publications; attention counts are matched records, not search volume or prediction probabilities.
What the source says
Publisher previewN-iX will build and support the AI, data engineering and LLM infrastructure behind COGNANO's antibody drug discovery research, across more than 300 mi [...]
This is a short preview supplied by the publisher. The charts above are separate ApplyDjinn observations. The complete story, including images and updates, remains with the publisher.